Latest filing published 02 Oct 2018 for Foamix Pharmaceuticals Ltd., €713.
Filing timeline
BuySaleInsider track record
Russell P. Elliott: trading record in brief
Russell P. Elliott discloses dealings in Foamix Pharmaceuticals Ltd. to SEC (Form 4). We count 7 filings; the first trade dates from 1 January 2018 and the latest from 1 October 2018.
Sales make up the whole of the open-market record (4 sales, €6,010). The rest of the record consists of 2 share grants and 1 option exercise.
On 2 October 2018 came the latest disclosure, an open-market sale for €713 in Foamix Pharmaceuticals Ltd. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Russell P. Elliott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 142 shares@ US$5.818.1% of flowOrdinary SharesSEC:0001178913-18-002611:0
- 142 shares@ US$5.107.1% of flowOrdinary SharesSEC:0001178913-18-002030:0
- 142 shares@ US$5.086.7% of flowOrdinary SharesSEC:0001178913-18-001112:0
- 817 shares@ US$6.1446.6% of flowOrdinary SharesSEC:0001178913-18-000771:0
- 8,750 shares0Ordinary SharesSEC:0001178913-18-000718:0
- 1,372 shares0Ordinary SharesSEC:0001178913-18-000265:0
- 555 shares@ US$5.9831.5% of flowOrdinary SharesSEC:0001178913-18-000265:1
7 of 7 declarations
